While efficacy is the main price mover, in my mind thats unlikely to be in under a year from the first dosing, and its only going to be in a few people, or potentially.
So that would be after August, and more likely it wont happen even this year.
And if it does it wont meet any statistical significance markers so they may not say much about it. Phase 2 and 3 are for that.
PYC - General Discussion, page-256
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.008(7.62%) |
Mkt cap ! $452.6M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.7¢ | $2.278M | 22.80M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 961 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 220013 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
-0.008 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.3¢ | 10.5¢ | 9.6¢ | 1146046 | ||
| Last updated 15.58pm 16/05/2024 ? | |||||
| PYC (ASX) Chart |